Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
17,443,866
-
Share change
-
+146,080
-
Total reported value
-
$31,743,198
-
Put/Call ratio
-
56%
-
Price per share
-
$1.82
-
Number of holders
-
45
-
Value change
-
+$264,551
-
Number of buys
-
12
-
Number of sells
-
19
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q3 2024
As of 30 Sep 2024,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,443,866 shares.
The largest 10 holders included
Privium Fund Management B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., EcoR1 Capital, LLC, M28 Capital Management LP, DAFNA Capital Management LLC, Ghost Tree Capital, LLC, MACQUARIE GROUP LTD, Ikarian Capital, LLC, Schonfeld Strategic Advisors LLC, and Monaco Asset Management SAM.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.